Knockdown of angiopoietin-like 4 inhibits the development of human gastric cancer.
In conclusion, these findings suggest that ANGPTL4 may be a new potential therapeutic target for GC.
PMID: 29436683 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research